Transmission cluster of multiclass highly drug-resistant HIV-1 among 9 men who have Sex with men in Seattle/King County, WA, 2005-2007

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 2, 2008, Pages 205-211

  Buskin, Susan E ^a,b   Ellis, Giovanina M ^c   Pepper, Gregory G ^b,c   Frenkel, Lisa M ^b,c   Pergam, Steven A ^b   Gottlieb, Geoffrey S ^b   Horwitch, Carrie ^d   Olliffe, Jeffrey F ^b   Johnson, Karen ^e   Shalit, Peter ^f   Heinen, Corinne ^b   Schwartz, Margot ^d   Wood, Robert W ^a,b  

^a PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d VIRGINIA MASON MEDICAL CENTER   (United States)

^e Country Doctor Community Clinic ^*  (United States)

^f SWEDISH MEDICAL CENTER   (United States)

Author keywords

Disease clustering; Highly active antiretroviral therapy; HIV; HIV 1; Multiple drug resistance

Indexed keywords

ABACAVIR; AMPRENAVIR PHOSPHATE; ATAZANAVIR; DARUNAVIR; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ETRAVIRINE; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; METHAMPHETAMINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RALTEGRAVIR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; TENOFOVIR DISOPROXIL; TIPRANAVIR; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; POL PROTEIN; VIRUS RNA;

ANTIVIRAL RESISTANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABUSE; GENETIC ANALYSIS; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LABORATORY TEST; MALE; MALE HOMOSEXUAL; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR; SEXUALITY; STRUCTURAL GENE; VIRUS STRAIN; VIRUS TRANSMISSION; CLASSIFICATION; CONTACT EXAMINATION; DISEASE TRANSMISSION; DNA SEQUENCE; DRUG EFFECT; EPIDEMIC; GENETICS; HOMOSEXUALITY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MULTIDRUG RESISTANCE; UNITED STATES; VIROLOGY;

ANTI-HIV AGENTS; CONTACT TRACING; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, VIRAL; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; PHYLOGENY; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEXUAL PARTNERS; WASHINGTON;

EID: 55249118583     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318185727e     Document Type: Article

References (29)

1. Oette M, Kaiser R, Daumer M, et al. Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing. J Acquir Immune Defic Syndr. 2006;41:573-581.
2. Weinstock HS, Zaidi I, Heneine W, et al. The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities. J Infect Dis. 2004;189:2174-2180.
3. Shet A, Berry L, Mohri H, et al. Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience. J Acquir Immune Defic Syndr. 2006;41:439-446.
4. Wheeler W, Mahle K, Bodnar U, et al. Antiretroviral drug-resistance mutations and subtypes in drug-naïve persons newly diagnosed with HIV-1 infection, US, March 2003 to October 2006. Presented at: Conference on Retroviruses and Opportunistic Infections; February 25-28; 2007; Los Angeles, CA. Poster # 648.
5. Ghosn J, Pellegrin I, Goujard C, et al. HIV-1 resistant strains acquired at the time of primary infection massively fuel, the cellular reservoir and persist for lengthy periods of time. AIDS. 2006;20:159-170.
6. CASCADE Virology Collaboration. The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy. AIDS. 2006;20:21-28.
7. Bhaskaran K, Pillay D, Walker AS, et al. Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters. AIDS. 2004;18:1471-1473.
8. Pillay D, Bhaskaran K, Jurriaans S, et al. The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy. AIDS. 2006;20:21-28.
9. Hammer SM, Saag MS, Schechter M, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA. 2006;296:827-843.
10. DHHS Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-infected Adults and Adolescents. Department of Health and Human Services; December 1, 2007:1-136. Available at: http://aidsinfo.nih.gov/contentfiles/Adultan dAdolescentGL.pdf. Accessed December 26, 2007.
11. Operskalski EA, Busch MP, Mosley JW, et al. Comparative rates of disease progression among persons infected with the same or different HIV-1 strains. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15: 145-150.
12. Smith DM, Richman DD, Little SJ. HIV superinfection. J Infect Dis. 2005;192:438-444.
13. Johnson VA, Brun-Vezinet F, Clotet B, et al. Update of the drug resistance mutations in HIV-1: Fall 2006. Top HIV Med. 2006;14:125-130.
14. Shafer RW, Rhee SY, Pillay D, et al. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS. 2007;21: 215-223.
15. Thompson JD, Gibson TJ, Plewniak F, et al. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997;25:4876-4882.
16. Swofford DL. PAUP*. Phylogenetic Analysis Using Parsimony (*and Other Methods). Version 4. Sunderland, MA: Sinauer Associates; 2002.
17. Pieniazek D, Wheeler W, Mahle K, et al. Frequency and mutation patterns of phylogenetically linked drug resistant strains among drug-naive Ppersons newly diagnosed with HIV 1-infection, United States, March 2003-October 2006 [B 14 - 4]. Presented at: National HIV Prevention Conference; December 2-5 2007; Atlanta, GA.
18. Lindstrom A, Ohlis A, Huigen M, et al. HIV-1 transmission cluster with M41L 'singleton' mutation and decreased transmission of resistance in newly diagnosed Swedish homosexual men. Antivir Ther. 2006; 11:1031-1039.
19. Drumright LN, Little SJ, Richman DD, et al. Age discordance and drug resistance predict clustering of HIV among recently-infected MSM in San Diego CA. Presented at: 14th Conference on Retroviruses and Opportunistic Infections (CROI); February 25-28, 2007; Los Angeles, CA. Abstract 654.
20. Leigh Brown AJ, Frost SD, Mathews WC, et al. Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population. J Infect Dis. 2003;187: 683-686.
21. de Mendoza C, Rodriguez C, Corral A, et al. Evidence for differences in the sexual transmission efficiency of HIV strains with distinct drug resistance genotypes. Clin Infect Dis. 2004;39:1231-1238.
22. Simon V, Padte N, Murray D, et al. Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infection. J Virol. 2003;77:7736-7745.
23. Little S, Frost S, Smith D, et al. Transmission of HIV drug resistance and treatment response. Presented at: Conference on Retroviruses and Opportunistic Infections; February 25-28,2007, Los Angeles, CA. Abstract 60.
24. Zaccarelii M, Tozzi V, Perno CF, et al. The challenge of antiretroviraldrug-resistant HIV: is there any possible clinical advantage. Curr HIV Res. 2004;2:283-292.
25. Taylor MM, Aynalem. G, Smith LV, et al. Methamphetamine use and sexual risk behaviours among men who have sex with men diagnosed with early syphilis in Los Angeles County. Int J STD AIDS. 2007;18: 93-97.
26. Plankey MW, Ostrow DG, Stall R, et al. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2007;45: 85-92.
27. Gorbach PM, Drumright LN, Javanbakht M, et al. Antiretroviral drug resistance and risk behavior among recently HIV-infected men who have sex with men. J Acquir Immune Defic Syndr Hum Retroviral. 2008;47: 639-643.
28. Colfax GN, Vittinghoff E, Grant R, et al. Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance. AIDS. 2007;21:239-241.
29. Mansergh G, Shouse RL, Marks G, et al. Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sex Transm Infect. 2006;82:131-134.